NUR 6011 Exam 1 – Advanced Pharmacology: Complete 200-Q Test Bank with NGN-Style Case Scenarios & Rationales | William Paterson University 2026/2027 Edition

,NUR 6011 EXAM 1 – ADVANCED PHARMACOLOGY

William Paterson University | Complete 200-Question
Test Bank | NGN-Style Questions & Case Scenarios |
2026/2027 Edition | 100% Pass Guarantee



EXAM 1

Topic Area Questions

Pharmacokinetics & Pharmacodynamics 1–25

Pharmacogenomics & Individual Variation 26–40

Autonomic Nervous System Pharmacology 41–65

Cardiovascular & Renal Pharmacology 66–90

Central Nervous System Pharmacology 91–115

Endocrine & Metabolic Pharmacology 116–130

Antimicrobial & Anti-Infective Pharmacology 131–155

Pain Management & Opioid Pharmacology 156–175

Hematologic & Immunologic Pharmacology 176–185

Comprehensive NGN Case Scenarios 186–200

,SECTION 1: PHARMACOKINETICS & PHARMACODYNAMICS (Questions 1–25)




1. A patient with renal impairment is prescribed a medication that is primarily
eliminated by the kidneys. Which pharmacokinetic parameter is most affected?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion

Answer: D) Excretion
Rationale: Renal impairment reduces the excretion of medications, leading to
accumulation and increased risk of toxicity. Lower doses or extended dosing
intervals are needed. This is a critical concept in pharmacokinetics.




2. A patient is started on a medication with a half-life of 24 hours. Approximately
how long will it take to reach steady-state concentrations?
A) 24 hours
B) 48 hours
C) 72 hours
D) 5 days (120 hours)

Answer: D) 5 days (120 hours)
Rationale: Steady-state is reached after approximately 5 half-lives. For a drug
with a 24-hour half-life, steady-state is achieved in about 5 days (5 × 24 = 120
hours).




3. A patient is prescribed a medication that is 95% protein-bound. What is the
clinical significance of this?
A) The drug has a rapid onset of action

, B) The drug is less likely to interact with other medications
k k k k k k k k k k




C) The drug is highly bound and may be displaced by other highly protein-bound
k k k k k k k k k k k k k




drugs, increasing free drug concentration
k k k k k




D) The drug is primarily excreted unchanged in the urine
k k k k k k k k k




Answer: C) The drug is highly bound and may be displaced by other highly protein-
k k k k k k k k k k k k k k




bound drugs, increasing free drug concentration
k k k k k




Rationale: Highly protein-bound drugs (≥90%) are at risk for displacement
k k k k k k k k k




interactions. When another drug competes for binding sites, the free (active)
k k k k k k k k k k k




concentration of the first drug increases, potentially causing toxicity.
k k k k k k k k k




4. A patient on warfarin (highly protein-bound) is started on a new medication that
k k k k k k k k k k k k k




also binds to albumin. Which effect should the nurse anticipate?
k k k k k k k k k k




A) Decreased warfarin effect
k k k




B) Increased warfarin effect (bleeding risk)
k k k k k




C) No change in warfarin effect
k k k k k




D) Increased warfarin metabolism
k k k




Answer: B) Increased warfarin effect (bleeding risk)
k k k k k k




Rationale: Displacement of warfarin from protein-binding sites increases free
k k k k k k k k




warfarin concentration, leading to increased anticoagulant effect and bleeding risk.
k k k k k k k k k k




This is a classic drug-drug interaction.
k k k k k k




5. A medication has a narrow therapeutic index. This means:
k k k k k k k k k




A) The drug has a wide safety margin
k k k k k k k




B) The drug requires close monitoring of serum levels
k k k k k k k k




C) The drug has no side effects
k k k k k k




D) The drug is always safe
k k k k k




. Answer: B) The drug requires close monitoring of serum levels
k k k k k k k k k k




Rationale: A narrow therapeutic index means there is a small difference between
k k k k k k k k k k k




the therapeutic dose and the toxic dose. Lithium, phenytoin, digoxin, and warfarin
k k k k k k k k k k k k




are examples requiring serum level monitoring
k k k k k k